🇺🇸 FDA
Patent

US 7332287

Methods and compositions for diagnosing breast cancer

granted A61KA61K48/00A61P

Quick answer

US patent 7332287 (Methods and compositions for diagnosing breast cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K48/00, A61P, A61P35/00, A61P35/04